About us
About us
Management
Board of Directors
Scientific Advisory Board
T1D Scientific Advisory Board
Science
Nimvec™ Platform
Gene therapy
Publications
Advisory Boards
Pipeline
Pipeline
Type 1 Diabetes
Obesity / T2DM
Multiple Sclerosis
Hemophilia B
Hemophilia A
Age-related Macular Degeneration
Partners
News & Events
Press releases
In the news
Meet us
Working here
Working here
Open positions
Contact
In the news
Mar 03, 2022
Europe’s Ophthalmology Scene Stays Hot for Biotech Funding
Mar 08, 2022
The Top European Biotech Investments in February 2022
Jan 21, 2022
Grant Supports Screening Platform for Potential Vaccine
Dec 03, 2021
Amarna Therapeutics raises €5M to accelerate its gene therapy towards clinical trials
Dec 03, 2021
Amarna Raises Over $5M to Advance Gene Therapy for Hemophilia B
Nov 10, 2021
New publication by our Process Development Scientist Thijs Gerritzen on the use of viral vectors for gene therapy
Oct 17, 2021
Amarna secures $11M for SV40 gene therapy platform
Oct 16, 2021
Amarna raises €10M to push gene therapy platform into clinic; Editas Medicine, AskBio join forces
Oct 16, 2021
Amarna Therapeutics Raises €10M in Funding
Sep 16, 2021
Amarna Therapeutics appointed new CEO
Jun 23, 2021
Amarna Therapeutics featured in Biotech NEWS & Life Sciences (Dutch)
Mar 01, 2021
Amarna Therapeutics featured in Nature Biopharmadealmakers
Apr 21, 2020
Amarna Therapeutics featured in Dutch television series Zo kan het ook
Dec 13, 2019
A big step in the treatment of autoimmune diseases
Feb 28, 2017
Stroopwaffels, Krokets and Biotechs – Meet the Top 10 in Leiden!
LOAD MORE
TERMS & CONDITIONS
PRIVACY POLICY / COOKIES
© 2024 AMARNA THERAPEUTICS
